Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
Titel:
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
Auteur:
Koch, Jan C Leha, Andreas Bidner, Helen Cordts, Isabell Dorst, Johannes Günther, René Zeller, Daniel Braun, Nathalie Metelmann, Moritz Corcia, Philippe De La Cruz, Elisa Weydt, Patrick Meyer, Thomas Großkreutz, Julian Soriani, Marie-Hélène Attarian, Shahram Weishaupt, Jochen H Weyen, Ute Kuttler, Josua Zurek, Gabriela Rogers, Mary-Louise Feneberg, Emily Deschauer, Marcus Neuwirth, Christoph Wuu, Joanne Ludolph, Albert C Schmidt, Jens Remane, Yvonne Camu, William Friede, Tim Benatar, Michael Weber, Markus Lingor, Paul
Verschenen in:
The lancet neurology
Paginering:
Jaargang 23 () nr. 11 pagina's 1133-1146
Jaar:
2024
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC 4.0 license